Molecular Therapy: Nucleic Acids
Издатель: Elsevier · ISSN 2162-2531 · 80 статей
- Replicating vs. non-replicating RNA therapeutics: Mechanisms, trade-offs, and future directions
- Gene therapy approaches for hereditary neuromuscular diseases
- Functional analysis of TTN uORFs reveals context-dependent translational regulation
- Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells
- Codon-dependent translation of N1-ethylpseudouridine-modified mRNA reduces innate immunity while preserving vaccine immunogenicity
- Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption
- An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
- Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa
- Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing
- Myogenic differentiation-derived small extracellular vesicles as a therapeutic strategy for miR-193b-3p-mediated muscle regeneration
- Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
- Segmented poly(A) tails with microRNA target sites confer tissue-specific regulation for mRNA therapeutics
- Aptamer-guided delivery of miR-126 suppresses glioblastoma stem-like cell invasion and tumor progression
- Bridging the antiviral gap: A BAC-based non-infectious SARS-CoV-2 replicon reveals potent antisense gapmers
- rAAV-mediated multi-miRNA delivery targeting MAPK pathway suppresses laser-induced choroidal neovascularization in mice
- Single-cell and intercellular communication analyses reveal DLL3 as a key regulator in the glioma tumor microenvironment
- CasNano: An ultracompact CRISPR-Cas12f with a GC-rich PAM for epigenome editing with therapeutic potential
- DNA oligonucleotides encoding suppressor tRNA induce readthrough of premature termination codon
- Structural insights into an aptainhibitor of the SARS-CoV-2 E protein using molecular docking, molecular dynamics, and biophysical analyses
- Combination of live-attenuated and adenovirus-based vaccines provides immediate and durable protection against Yersinia pestis in mice
- Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma
- RNA-encoded PGT121-LS anti-HIV antibody: Comprehensive preclinical characterization and translational pharmacokinetics
- Genome-wide CRISPRa screens identify modulators of CAR T survival across diverse tumor cytokine milieus
- Targeting miR-21 ameliorates colitis by restoring Th17/Treg balance through direct inhibition of Smad7/Ski
- Morpholino-mediated splice switching of NELFE suppresses hepatocellular carcinoma cell phenotypes in vitro and in vivo
- Cas13d-mediated viral RNA degradation leads to potent antiviral control against both positive and negative sense RNA viruses
- Minimal indel-inducing and window-adjustable base editing using inactive Cas12b effectors
- cGAS-mediated immunogenicity impairs the stability and safety of LNP-encapsulated DNA in vivo
- Systemic and local delivery of siRNA to the CNS and periphery via anti-IGF1R antibody conjugation
- Targeted insertion of partial CFTR cDNA replicates native CFTR expression with restored channel function in CF airway epithelium